Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for PTKFF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 1.850B
March 31, 2026 1.882B
December 31, 2025 1.841B
September 30, 2025 1.806B
June 30, 2025 1.818B
March 31, 2025 1.847B
December 31, 2024 1.829B
September 30, 2024 1.899B
June 30, 2024 1.744B
March 31, 2024 1.827B
December 31, 2023 1.757B
September 30, 2023 1.759B
June 30, 2023 1.829B
March 31, 2023 1.883B
December 31, 2022 1.750B
September 30, 2022 1.720B
June 30, 2022 1.696B
March 31, 2022 1.870B
December 31, 2021 1.801B
September 30, 2021 1.695B
June 30, 2021 1.614B
March 31, 2021 1.648B
December 31, 2020 1.606B
September 30, 2020 1.509B
June 30, 2020 1.546B
Date Value
March 31, 2020 1.357B
December 31, 2019 1.460B
September 30, 2019 1.380B
June 30, 2019 1.332B
March 31, 2019 1.347B
December 31, 2018 1.262B
September 30, 2018 1.176B
June 30, 2018 1.249B
March 31, 2018 1.257B
December 31, 2017 1.225B
September 30, 2017 1.205B
June 30, 2017 1.233B
March 31, 2017 1.194B
December 31, 2016 1.130B
September 30, 2016 1.125B
June 30, 2016 1.077B
March 31, 2016 1.089B
December 31, 2015 993.57M
September 30, 2015 905.07M
June 30, 2015 954.33M
March 31, 2015 995.78M
December 31, 2014 1.003B
September 30, 2014 986.28M
June 30, 2014 1.040B
March 31, 2014 1.023B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Avadel Pharmaceuticals Plc 199.45M

Total Assets (Quarterly) Related Metrics